Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Prospective, Randomized and Subject Blinded Comparative Study of AxoGuard® Nerve Cap and Neurectomy for the Treatment of Symptomatic Neuroma and Prevention of Recurrent End-Neuroma Pain

NCT03940963 is registered in ClinicalTrials.gov with Axogen Corporation as lead sponsor.

NCT NCT03940963
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03940963 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Prospective, Randomized and Subject Blinded Comparative Study of AxoGuard® Nerve Cap and Neurectomy for the Treatment of Symptomatic Neuroma and Prevention of Recurrent End-Neuroma Pain
Lead sponsor
Axogen Corporation
Phase
Not applicable
Overall status
Completed
Start date
October 10, 2018
Completion date
July 17, 2023
Enrollment
86 (actual)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

chronic nerve pain, morton's neuroma, symptomatic neuroma